Aquilanti, Elisa
Herrity, Elizabeth
Nayak, Lakshmi
Funding for this research was provided by:
Leukemia and Lymphoma Society
National Institutes of Health
Article History
Accepted: 2 September 2024
First Online: 11 October 2024
Declarations
:
: Dr. Nayak receives grant support from the Leukemia and Lymphoma Society and the National Institutes of Health. She receives royalties or license fees from Wolters Kluwer. She receives consultation fees from BraveBio, ONO and Genmab. She receives payment or honoraria from ONO. She receives support for attending meetings and/or travel received from ONO. She participates in Data Safety Monitoring Board or Advisory Board for ONO and Kite/Gilead.
: This article does not contain any studies with human or animal subjects performed by any of the authors.